4//SEC Filing
Sirtris Pharmaceuticals, Inc. 4
Accession 0001179110-07-011775
CIK 0001388775operating
Filed
May 30, 8:00 PM ET
Accepted
May 31, 3:38 PM ET
Size
10.8 KB
Accession
0001179110-07-011775
Insider Transaction Report
Form 4
Sinclair David
Director
Transactions
- Conversion
Sereis C-1 Redeemable Convertible Preferred Stock
2007-05-29−14,881→ 0 total→ Common Stock (2,834 underlying) - Conversion
Series A Redeemable Convertible Preferred Stock
2007-05-29−50,000→ 0 total→ Common Stock (9,524 underlying) - Conversion
Common Stock
2007-05-29+2,834→ 162,834 total - Conversion
Common Stock
2007-05-29+9,524→ 160,000 total
Footnotes (2)
- [F1]Upon the closing of the Issuer's initial public offering, each 5.25 shares of Series A Redeemable Convertible Preferred Stock converted to 1 share of Common Stock.
- [F2]Upon the closing of the Issuer's initial public offering, each 5.25 shares of Series C-1 Redeemable Convertible Preferred Stock converted to 1 share of Common Stock.
Documents
Issuer
Sirtris Pharmaceuticals, Inc.
CIK 0001388775
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001388775
Filing Metadata
- Form type
- 4
- Filed
- May 30, 8:00 PM ET
- Accepted
- May 31, 3:38 PM ET
- Size
- 10.8 KB